Virtual Thyroid! The USC Peter A. Singer Thyroid Symposium 2020 continues the tradition of dedication to providing a comprehensive and current update in the management of thyroid disease. Throughout its history, this symposium has sought to educate and foster enthusiasm about thyroid care in an increasingly complex and evolving field, and despite the challenges, this year will be no exception.

New options abound for many important thyroid conditions and the clinical care of patients with thyroid disorders is increasingly complex and informed by evidence-based management strategies. The program presents forward-looking perspectives representing the most current state of thyroid medicine and what the future is likely to hold.

For 2020, the program goes virtual with topics to the generalist treating patients with thyroid conditions, such as challenges in levothyroxine replacement and thyroid disease and COVID-19 to topics for the rising expert such as the management of thyroid eye disease, risks of radioactive iodide, targeted therapies for thyroid cancer, immunotherapy-related thyroidopathy, and pre-operative evaluations.

Presentations combining evidence-based medicine and clinical experience, challenging cases, and audience questions, will help inform practice decisions in an era of complex clinical problems. We hope you enjoy the meeting!

Target Audience

This course is intended for endocrinologists, primary care providers, fellows and other healthcare professionals seeking to enhance their understanding of thyroid diseases and treatment options in order to select the optimal management for their patients.

Educational Objectives

 By the end of the course, participants will be able to:

• Compare treatment options for thyroid eye disease. 
• Instruct patients regarding fertility risks of radioactive iodine ablation. 
• Advise patients regarding thyroid disease and the risk of COVID-19. 
• Evaluate and manage thyroid disfunction in patients receiving immunotherapy. 
• Recognize new therapeutic targets for thyroid cancer. 
• Recommend necessary evaluations prior to thyroid surgery. 
• Manage difficult-to-control TSH in patients taking levothyroxine. 

Accreditation

The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Keck School of Medicine of the University of Southern California designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The following may apply AMA PRA Category 1 Credit(s)™  for license renewal: Registered Nurses may report up to 3.75 credit hour(s) toward the CME requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number. Physician’s Assistants: The National Commission on Certification of Physicians’ Assistants states that AMA PRA Category 1 Credits™  accredited courses are acceptable CME requirements for recertification.